KMT2C and urogenital neoplasm: High-throughput sequencing methods such as single-cell RNA-seq have enabled deep characterization of the prostate BCC genome, revealing key driver mutations of CASC5, NUTM1, PTPRC, KMT2C, and TBX3, genes also involved in chromatin remodeling and stem cell regulation.3